These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32851439)

  • 21. The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Huang CP; Huang WJ; Chang YH; Lien CS; Chkhotua A; Elterman DS
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):576-582. PubMed ID: 35641601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
    Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
    Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are the UroLift(®) implants an alternative for the treatment of benign prostatic hyperplasia? Short-term results and predictive factors of failure].
    Beurrier S; Peyromaure M; Belas O; Barry Delongchamps N
    Prog Urol; 2015 Jul; 25(9):523-9. PubMed ID: 25934591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia.
    McVary KT; El-Arabi A; Roehrborn C
    Sex Med; 2021 Dec; 9(6):100454. PubMed ID: 34731779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic Urethral Lift Versus Transurethral Resection of the Prostate (TURP).
    Magistro G; Stief CG; Gratzke C
    Curr Urol Rep; 2017 Aug; 18(10):82. PubMed ID: 28852996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prostatic urethral lift using Urolift® system for benign prostatic hyperplasia: 7years experience].
    Userovici M; Ochoa A; Anract J; Beurrier S; Peyromaure M; Barry Delongchamps N
    Prog Urol; 2020 Mar; 30(3):147-154. PubMed ID: 32127310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC; Fitzpatrick JM;
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Singh DV; Mete UK; Mandal AK; Singh SK
    J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What's New in TIND?
    Marcon J; Magistro G; Stief CG; Grimm T
    Eur Urol Focus; 2018 Jan; 4(1):40-42. PubMed ID: 29705283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified holmium laser enucleation for benign prostatic obstruction to preserve sexual and ejaculatory function.
    Long Depaquit T; Baboudjian M; Chiron P; Corral R; Anastay V; Bastide C; Toledano H
    Fr J Urol; 2024 Mar; 34(2):102581. PubMed ID: 38717462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Office-based therapies for benign prostatic hyperplasia : Update on new minimally invasive surgery therapies].
    Baboudjian M; Pradere B
    Prog Urol; 2021 Nov; 31(14):931-936. PubMed ID: 34456141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
    Desai MM; Singh A; Abhishek S; Laddha A; Pandya H; Ashrafi AN; Ganpule AP; Roehrborn CG; Thomas AJ; Desai M; Sabnis RB
    BJU Int; 2018 Jun; 121(6):945-951. PubMed ID: 29319914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study).
    Kaplan SA; Moss JL; Freedman SJ
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):531-536. PubMed ID: 38684918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
    Rukstalis D; Rashid P; Bogache WK; Tutrone RF; Barkin J; Chin PT; Woo HH; Cantwell AL; Cowan BE; Bolton DM
    BJU Int; 2016 Oct; 118 Suppl 3():14-22. PubMed ID: 27684483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.